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Abstract
The diagnosis and treatment of clinical electrophysiology has a long and fascinating history.
From the earliest time, no clinical symptom impressed the patient (and the physician) more
than an irregular heart beat. Although ancient Chinese pulse theory laid the foundation for the
study of arrhythmias and clinical electrophysiology in the 5th century BC, the most significant
breakthrough in the identification and treatment of cardiac arrhythmias first occurred in this
century. In the last decades, our knowledge of electrophysiology and pharmacology has in-
creased exponentially. The enormous clinical significance of cardiac rhythm disturbances has
favoured these advances. On the one hand, patients live longer and thus are more likely to
experience arrhythmias. On the other hand, circulatory problems of the cardiac vessels have
increased enormously, and this has been identified as the primary cause of cardiac rhythm
disorders. Coronary heart disease has become not just the most significant disease of all, based
on the statistics for cause of death. Arrhythmias are the main complication of ischemic heart
disease, and they have been directly linked to the frequent arrhythmogenic sudden death
syndrome, which is now presumed to be an avoidable “electrical accident” of the heart.
A retrospective look — often charming in its own right — may not only make it easier to sort
through the copious details of this field and so become oriented in this universe of important
and less important facts; it may also assist the observer in a chronological vantage point of the
subject. The study of clinical electrophysiology is no dry compendium of facts and figures, but
rather a dynamic field of study evolving out of the competition between various ideas, inten-
tions and theories. (Cardiol J 2008; 15: 293–297)
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Introduction
The first physician and legendary founder of
modern scientifically based medicine was Hippocra-
tes. As the spiritual rector of the Hippocratic ma-
nuscript collection (Corpus hippocraticum), he ga-
ined paramount importance in the medical history
of the West for establishing the medical professions
tradition of education. As an “Asclepiad” and head
of the School of Cos, he was thought to have been,
according to tradition a 19th generation descendent
of Asclepius the legendary god of medical science
in Greek mythology [1].
Hippocrates stated in his Aphorisms (Section II,
No. 41) “Those who are subject to frequent and se-
vere fainting attacks without obvious cause die sud-
denly.” (Fig. 1).
This might be the first description of sudden car-
diac death. The Aphorism describes recurrent syn-
cope in otherwise healthy individuals. These observa-
tions could be linked to electrical diseases as long
QT syndrome, arrhythmogenic right ventricular
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Table 1. Historical perspectives of clinical electrophysiology.
1580 Mercuriale G (1530–1606) — Ubi pulsus sit rarus semper expectanda est syncope [2]
1717 Gerbezius M (1658–1718) — Constitutio Anni 1717 a.A.D. Marco Gerbezio Labaco 10. Decem. descripta.
Miscellanea Emphemerides Academiae Naturae [3]
1761 Morgagni GB (1682–1771) — De sedibus et causis morborum per anatomen indagatis [4]
1791 Galvani L (1737–1798) — De viribus electricitatis in motu musculari commentarius [5]
1800 Bichat MFX (1771–1802) — Recherches physiologiques sur la vie et la mort [6]
1804 Aldini G (1762–1834) — Theoretical and experimental essay on galvanism with a series of
experiments conducted in the presence of representatives of the national Institute of France
at various amphitheatres in London [7]
1827/1846 Adams R (1791–1875), Stokes W (1804–1878) — Cases of diseases of the heart accompanied with
pathological observations; observations of some cases off a permanently slow pulse [8, 9]
1872 Duchenne de Bologne GBA (1806–1875) — On localized electrical stimulation and its pathological
and therapeutic application by induced and galvanized current, both interrupted and continuous [10]
1882 von Ziemssen H (1829–1902) — Studies on the motions of the human heart as well as the mechanical
and electrical excitability of the heart and phrenic nerve, observed in the case of the exposed heart
of Catharina Serafin [11]
1890 Huchard H — La maladie de Adams-Stokes (Adams-Stokes syndrome)
1932 Hyan AS — Resuscitation of the stopped heart by intracardial therapy. II. Experimental use of an
artificial pacemaker [12]
1952 Zoll PB — Resuscitation of the heart in ventricular standstill by external electrical stimulation [13]
1958 Elmquist R, Senning A — An implantable pacemaker for the heart [14]
1958 Furman S, Robinson G — The use of an intracardiac pacemaker in the correction of total heart block [15]
1961 Bouvrain Y, Zacouto F — L’entrainment èlectrosystolique du coeur [16]
1962 Lown B et al. — Bifocal demand pacing [17]
1969 Berkovits BV et al. — Bifocal demand pacing [18]
1972 Wellens HJJ et al. — Electrical stimulation of the heart in patients with ventricular tachycardia [19]
1975 Zipes DP et al. — Termination of ventricular fibrillation in dogs by depolarizing a critical amount
of myocardium [20]
1978 Josephson ME et al. — Recurrent sustained ventricular tachycardia [21]
1980 Mirowski M et al. — Termination of malignant ventricular arrhythmias with an implanted automatic
defibrillator in human beings [22]
1982 Gallagher JJ et al. — Catheter technique for closed-chest ablation of the atrioventricular conduction
system: A therapeutic alternative for the treatment of refractory supraventricular tachycardia [23]
1982 Scheinman MM et al. — Transvenous catheter technique for induction of damage to the atrioventricular
conduction system [24]
1982 Lüderitz B et al. — Therapeutic pacing in tachyarrhythmias by implanted pace-makers [25]
1985 Manz M et al. — Antitachycardia pacemaker (Tachylog) and automatic implantable defibrillator (AID):
Combined use in ventricular tachyarrhythmias [26]
1987 Borggrefe M et al. — High frequency alternating current ablation of an accessory pathway in humans [27]
1988 Saksena S, Parsonnet V — Implantation of a cardioverter-defibrillator without thoracotomy using a triple
electrode system [28]
1991 Jackman WM et al. — Catheter ablation of accessory atrioventricular pathways (Wolff-Parkinson-White
syndrome) by radiofrequency current [29]
1991 Kuck KH et al. — Radiofrequency current catheter ablation of accessory path ways [30]
1994 Daubert C et al. — Permanent atrial resynchronisation by synchronous bi-atrial pacing in the preventive
treatment of atrial flutter associated with high degree interatrial block [31]
1994 Cazeau S et al. — Four chamber pacing in dilated cardiomyopathy [32]
1994 Wiiffels MCEF et al. — Atrial fibrillation begets atrial fibrillation [33]
1995 Camm AJ et al. — Implantable atrial defibrillator [34]
1997 Jung W et al. — First worldwide implantation of an arrhythmia management system [35]
1998 Haissaguerre M et al. — Spontaneous initiation of atrial fibrillation by ectopic beats originating in the
pulmonary veins [36]
1999 Josephson M et al. — Hybrid pharmacologic and ablative therapy: A novel and effective approach for
the management of atrial fibrillation [37]
2006 Allessie MA — Mechanism of atrial fibrillation — an anatomical 3D Labyrinth of multiple narrow
wavelets (World Congress of Cardiology, Barcelona, Spain) [38]
2007 Calkins HG et al. — HRS/EHRA/ECAS Consensus Statement on Atrial Fibrillation [39]
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dysplasia (ARVD) and arrhythmogenic right ventri-
cular cardiomyopathy (ARVC; Naxos disease), Bru-
gada syndrome, hypertrophic cardiomyopathy etc.
Aside from the discovery of the cardiac conduc-
tion system and advancements in the electrothera-
py of cardiac arrhythmias (Table 1) the development
of electrocardiography was the key issue for a more
detailed understanding of repolarization as a cause
and a correlate of cardiac disorders particularly sud-
den death.
Carl Friedrich Wilhelm Ludwig (1816–1895)
developed an instrument to record hemodynamic
and other physiologic events accurately. For exam-
ple, by simultaneously recording the pulse wave and
respiratory pattern, he first described sinus arrhy-
thmia in 1847. The first registration of ventricular
fibrillation is depicted on Figure 2.
Waller’s classic demonstration of the human
ECG (called the electrocardiogram at the time al-
ready) from the intact human heart took place at
St. Mary’s Hospital, London, in May 1887, with sur-
face electrodes strapped to the front and back of the
chest. There were only two distorted deflections:
ventricular depolarization and repolarization. The
P-wave was not discernible with the 1887 appara-
tus. This historic event in 1887 was also witnessed
by Einthoven. The following year, Waller recorded
the ECG by using saline jars in which the extremi-
ties were immersed. Einthoven, himself, credited
Waller with the first human ECG (Fig. 3) [1].
Whereas the qualitative and quantitative me-
asurement of the pulse may be understood as a star-
ting point in arrhythmia diagnoses, true understan-
ding of cardiac rhythm disorders really began with
electrocardiography using the string galvanometer
refined by Einthoven [40].
Interventional electrophysiology
The invasive electrophysiologic diagnostic and
stimulation procedure is a heart catheter technique
based on the historical maneuver performed by
Werner Forssmann. Following this pioneer, Scher-
lag and colleagues described the first intracardiac ca-
theter recordings of the His bundle in 1969, where-
as Dirk Durrer and Henrick J.J. Wellens were the
first to execute programmed stimulation in man [41].
The programmed stimulation technique has in
first-line been used to induce ventricular tachycar-
dia and to elucidate the mechanisms of tachycardias
in the Wolff-Parkinson-White syndrome. Electro-
physiologic testing was then used more and more
Figure 1. Hippocrates from Cos.
Figure 3. The first human electrocardiogram (ECG),
recorded by Waller in 1897.
Figure 2. First graphic documentation of ventricular
fibrillation. In 1894, while investigating vagal influences
on cardiac activity, M. Hoffa, in Carl Ludwig’s laborato-
ry, documented bizarre unregulated actions of the ven-
tricles when exposed directly to strong faradic or con-
stant currents. The disorder affected both rhythm and
intensity, persisted after termination of electroexcita-
tion and stopped cardiac output. The atria did not parti-
cipate in the arrhythmia.
Hoffa M, Ludwig C. Ztschrft Rat Med, 1850; 9: 107
”Those who suffer from
frequent and strong fainis
without any manifest cause
die suddenly.„
Hippocrates (circa 466–377 BC)
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to guide pharmacological therapy and to delineate
the electrophysiologic effects of drugs on the nor-
mal and diseased myocardium. The registration of
the action potential in the experimental laboratory
and in the intact human heart via catheter techni-
que substantially changed our understanding about
mechanisms in cellular depolarization and repola-
rization, antiarrhythmic drug effects and sudden
cardiac death and arrhythmogenesis [42].
Torsade de pointes tachycardia
The typical arrhythmia of patients with conge-
nital or acquired Long QT syndrome is the torsade
de pointes tachycardia (TdP). This specific form of
a dangerous polymorphic ventricular tachyarrhyth-
mia is characterized by a repetitive change of the
main QRS vector during tachycardia in the presence
of a prolonged repolarization. François Desserten-
ne [43] first described the TdP morphology in an
80-year-old female patient with intermittent atrioven-
tricular block (Fig. 4). The cause of her recurring syn-
copal episodes was the TdP tachycardia rather than
the bradycardia, as it had primarily been suspected.
Coming back to Hippocrates, we can say, that
he was the first to describe sudden cardiac death
based on electrical diseases of the heart. Hippocra-
tes’ observations and intentions inspired experi-
mental and clinical science to detect and to elabo-
rate genetics, mechanisms, treatment and preven-
tion of sudden death, one of the most important
causes of mortality today (Table 2).
Figure 4. First description of torsade des pointes waves
in 1966 by Dessertenne. He observed this rhythm
disorder in an 80-year-old female patient with a complete
intermittent atrioventricular block.
La tachycardie ventriculaire à deux foyers opposés variables
Par F. Dessertenne
Table 2. Diseases likely to fit Hippocrates’ aphorism.
Arrhythmogenic disease Risk of SCD (% per year) Genetic component?
Hypertrophic cardiomyopathy 1–4 +
Arrhythmogenic RV dysplasia 3 +
Dilated cardiomyopathy 4 +
Long QT syndrome 1–5 +
Wolff-Parkinson-White syndrome 0.15 +
Idiopathic ventricular tachycardia High Unknown
Brugada syndrome 10 +
Naxos disease (ARVC) High +
ARVC — arrhythmogenic right ventricular cardiomyopathy; RV — right ventricular; SCD — sudden cardiac death
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